Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

By L. Stewart Massad, MD

Advertisement

Articles by By L. Stewart Massad, MD

gynecologic cancer

Cervical Cancer Screening Guidelines Updated: Changes Mean Less Intrusive Prevention Strategies, Lower Morbidity

ByBy L. Stewart Massad, MD
March 25th 2013

L. Stewart Massad, MD, discusses recent updates to guidelines for cervical cancer screening intended to implement prevention strategies that are less intrusive and reduce morbidity.

Advertisement

Latest Updated Articles

  • gynecologic cancer
    Cervical Cancer Screening Guidelines Updated: Changes Mean Less Intrusive Prevention Strategies, Lower Morbidity

    March 25th 2013



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses

2

First-Line Treatment Choice and Altering Resistance in EGFR-Mutant NSCLC

3

ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care

4

Early Amivantamab Experience and Subcutaneous Dosing in COPERNICUS

5

FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us